February 4, 2015
Fitch Even partner Kendrew H. Colton was quoted in an article published online in this week’s edition of Chemical & Engineering News, a publication of the American Chemical Society.
The article, titled "Supreme Court Sends Biofuels and Pharmaceutical Patent Cases Back to Appeals Court," reports that the Supreme Court sent three patent infringement cases back to the Federal Circuit in light of the high court’s recent ruling in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
In his comments, Ken explained, “The Supreme Court is trying to get the Federal Circuit to mainstream its handling of appeals consistent with how other appellate courts hear and decide appeals.”
More information on this latest development following Teva can be found in a recent Fitch Even IP Alert here.
IP Alert | Federal Circuit Clarifies Equitable Intervening Rights Extend Beyond Protecting Monetary InvestmentsFebruary 26, 2021
On February 19, in John Bean Technologies Corp. v. Morris & Associates, Inc., the Federal Circuit clarified the types of investments that may be entitled to protections under the doctrine of equitable intervening rights, holding that it can extend beyond a monetary investment. Read more
IP Alert | Knowledge Within the Art Does Not Save Means-Plus-Function Claim Term Lacking Corresponding StructureFebruary 19, 2021
On February 12, in Synchronoss Technologies, Inc. v. Dropbox, Inc., the Federal Circuit affirmed that certain of Synchronoss's claims were invalid for indefiniteness, since the claims included a means-plus-function claim term that did not have adequate structural support in the specification. Read more